Lung transplantation is a definitive treatment for end-stage lung disease and can significantly improve patient prognosis. However, postoperative complications such as infection, rejection, ischemia-reperfusion injury and chronic lung allograft dysfunction intertwine to form a complex pathological network, posing persistent challenges to long-term patient survival. In 2025, research teams worldwide have made systematic progress in the field of basic lung transplantation research. By integrating cutting-edge technologies including single-cell multi-omics, spatial transcriptomics and novel animal models, significant breakthroughs have been achieved in the evolutionary dynamics of drug-resistant infections, molecular mechanisms of immune regulation, programmed cell death, optimization of donor lung protection strategies and early warning of chronic lung allograft dysfunction. This article systematically reviews the representative advances in basic lung transplantation research worldwide in 2025, and deeply analyzes the implications of mechanistic breakthroughs for optimizing diagnosis and treatment strategies, aiming to anchor the direction for innovative breakthroughs and clinical translation in basic lung transplantation research.

Mindfulness-based psychotherapy was developed from mindfulness-based psychotherapy,including mindfulness-based stress reduction therapy,mindfulness-based cognitive therapy,dialectical behavior therapy,acceptance and commitment therapy.Mindfulness therapy alleviates the symptoms of mental illness by regulating the cognitive and emotional systems.A large number of studies have shown that mindfulness therapy is helpful in the treatment of depression,anxiety,substance dependence,post-traumatic stress disorder,eating disorder,schizophrenia,bipolar disorder and other mental diseases.The therapeutic effect in depression and anxiety is the same as that of first-line treatment,which provides a new idea for the treatment of mental diseases.

Objective: To explore the influence of nursing intervention on bone health of breast cancer patients in aromatase inhibitors (AIs) treatment. Methods: Totally 120 breast cancer patients receiving AIs treatment were randomly divided into the observation group (60 cases) and the control group (60 cases), and bone mineral density was measured. After that, the control group was routinely instructed to take calcium supplements, given health lectures, and real-time management. The observation group were given whole-process bone health management intervention based on "Internet+" on the basis of routine nursing. After 1 year, osteoporosis knowledge questionnaire and bone mineral density test were conducted in the two groups. Results: Score of Osteoporosis Knowledge Test of observation group was 21.38±3.29, and 12.54±5.03 of control group, comparing the two groups was statistically significant (t=10.27, P < 0.05); before intervention bone mineral density of observation group was (1.042±0.138) g/cm², and (1.058±0.127) g/cm² of control group, comparing the two groups has no statistical significance, comparable (t=1.053, P > 0.05); after intervention the bone mineral density of observation group was (0.951±0.108) g/cm², and (0.854±0.100) g/cm² of control group, the comparison between the two groups was statistically significant (t=5.937, P<0.05). After intervention, the incidence of osteoporosis in the observation group was 21.67% (13/60), which was significantly higher than 35.00% (21/60) in the control group (χ²=4.279, P<0.05). Conclusion Whole-course nursing intervention can promote bone health of AIs patients with breast cancer.